OpenAlex
PricingAboutJobs
Log inGet started
Work

The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK

HTML

Year: 2015
Type: article
Source: Thrombosis and Haemostasis
DOI: 10.1160/th14-12-1027
Authors: Anamaria Vera Jugrin, Anastasia Ustyugova, Michael Urbich, Tom Sunderland, Mark Lamotte
Institutions: Boehringer Ingelheim (Germany), Boehringer Ingelheim (United Kingdom)
Language: English

Topic: Venous Thromboembolism Diagnosis and Management
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dabigatran etexilate, warfarin, venous thromboembolism, deep vein thrombosis, pulmonary embolism, long-term anticoagulation, cost-utility analysis, quality-adjusted life years, cost per QALY, bleeding risk, anticoagulation, National Health Service costs
SDG: Good health and well-being

Open Access status: closed

Funder: Boehringer Ingelheim
OpenAlex ID: W2163451556
FWCI: 2.409
Cites: 25
Cited by: 12
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security